ArticleJournal of the National Cancer Institute2025

RecOVARY? Using anti-Müllerian hormone to predict ovarian function after anti-HER2 therapy for early breast cancer.

Lynn K Symonds et al.PubMed ↗Publisher ↗

No numbers read from the abstract.